2015 VAM: 3302 - EAACI: Bringing Molecular Diagnosis and Treatment Closer to the Bedside: European Trials
This recording will describe new developments in the use of molecular components in diagnosis and treatment of different allergic diseases. It is intended for both clinicians and basic scientists. **Alt. moderator TBA; EAACI President-Elect, decided in June.
AMA PRA Category 1 Credits™: 1.25
Credit must be claimed by June 30, 2017. Any credit request on or after July 1, 2017 will be subject to an administrative fee.
System requirements: Two most recent versions of Internet Explorer, Safari, Google Chrome, and Firefox
Allied Health Professionals
Upon completion of this activity, participants will be able to:
1. Recognize and discuss the advances in the use of modified allergens for immunotherapy
2. Describe the potential of and use for a chip measuring rhinovirus exposure in relation to respiratory allergy activity and exacerbations
3. Identify the usefulness of molecular components for food allergy diagnosis
Prof. Lars K. Poulsen, PhD FAAAAI, Copenhagen University Hospital, Hellerup, Denmark
Prof. Rudolf Valenta, MD, Medical University of Vienna AKH, Wien, Austria
Prof. Ronald Van Ree, PhD FAAAAI, Academic Medical Centre, University of Amsterdam
- 1.25 AttendanceAttendance credit.
- 1.25 CECE credit.
- 1.25 CMECME credit.